Skip to Main Content

Advertisement

Close

ASH Clinical News
ASH News Daily
ASH-SAP
Blood Journals
Hematology
The Hematologist
International
ASH
- ASH Home
- Research
- Education
- Advocacy
- Meetings
- Publications
- ASH Store

header search

search input Search input auto suggest

filter your search

Search

Menu

Issues
- Current Issue
- All Issues
First edition
Abstracts
Collections
Author Center
About

Skip Nav Destination

Issue Archive

Select Decade

Select Year

Issue

Volume 132, Issue 10

September 6 2018

In this Issue

BLOOD COMMENTARIES
PLENARY PAPER
PERSPECTIVE
BLOOD SPOTLIGHT
CLINICAL TRIALS AND OBSERVATIONS
HEMATOPOIESIS AND STEM CELLS
LYMPHOID NEOPLASIA
THROMBOSIS AND HEMOSTASIS
BLOOD WORK

Table of Contents

BLOOD COMMENTARIES

Red Cells, Iron, and Erythropoiesis

Heme, whence come thy carbon building blocks?

Tracey A. Rouault

View Articletitled, Heme, whence come thy carbon building blocks?

CLINICAL TRIALS AND OBSERVATIONS

CART19 in Hodgkin lymphoma: are we driving the right model?
Clinical Trials & Observations

Catherine S. Diefenbach

View Articletitled, CART19 in Hodgkin lymphoma: are we driving the right model?

Lymphoid Neoplasia

A miRaculous new therapy in myeloma?

Lawrence H. Boise

View Articletitled, A miRaculous new therapy in myeloma?

THROMBOSIS AND HEMOSTASIS

ADAMTS-13 in traumatic brain injury?

Rosemary Kozar

View Articletitled, ADAMTS-13 in traumatic brain injury?

PLENARY PAPER

Red Cells, Iron, and Erythropoiesis

Glutamine via α-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis

Joseph S. Burch,Jason R. Marcero,John Alan Maschek,James E. Cox,Laurie K. Jackson,Amy E. Medlock,John D. Phillips,Harry A. Dailey, Jr

View Articletitled, Glutamine via α-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis

Supplemental data

PERSPECTIVE

Insight into origins, mechanisms, and utility of DNA methylation in B-cell malignancies

Christopher C. Oakes,Jose I. Martin-Subero

View Articletitled, Insight into origins, mechanisms, and utility of DNA methylation in B-cell malignancies

BLOOD SPOTLIGHT

BCL-2 inhibition in AML: an unexpected bonus?
Clinical Trials & Observations

Marina Konopleva,Anthony Letai

View Articletitled, BCL-2 inhibition in AML: an unexpected bonus?

CLINICAL TRIALS AND OBSERVATIONS

CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET
Clinical Trials & Observations

David J. Straus,Sin-Ho Jung,Brandelyn Pitcher,Lale Kostakoglu,John C. Grecula,Eric D. Hsi,Heiko Schöder,Leslie L. Popplewell,Julie E. Chang,Craig H. Moskowitz,Nina Wagner-Johnston,John P. Leonard,Jonathan W. Friedberg,Brad S. Kahl,Bruce D. Cheson,Nancy L. Bartlett

View Articletitled, CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET

Supplemental data

Nonviral RNA chimeric antigen receptor–modified T cells in patients with Hodgkin lymphoma
Clinical Trials & Observations Brief Report

Jakub Svoboda,Susan R. Rheingold,Saar I. Gill,Stephan A. Grupp,Simon F. Lacey,Irina Kulikovskaya,Megan M. Suhoski,J. Joseph Melenhorst,Brandon Loudon,Anthony R. Mato,Sunita Dwivedy Nasta,Daniel J. Landsburg,Matthew R. Youngman,Bruce L. Levine,David L. Porter,Carl H. June,Stephen J. Schuster

View Articletitled, Nonviral RNA chimeric antigen receptor–modified T cells in patients with Hodgkin lymphoma

HEMATOPOIESIS AND STEM CELLS

Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-β1 secretion and hematopoiesis in mice

Maegan Capitano,Liang Zhao,Scott Cooper,Chelsea Thorsheim,Aae Suzuki,Xinxin Huang,Alexander L. Dent,Michael S. Marks,Charles S. Abrams,Hal E. Broxmeyer

View Articletitled, Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-β1 secretion and hematopoiesis in mice

Supplemental data

LYMPHOID NEOPLASIA

Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLL

Sean D. Reiff,Elizabeth M. Muhowski,Daphne Guinn,Amy Lehman,Catherine A. Fabian,Carolyn Cheney,Rose Mantel,Lisa Smith,Amy J. Johnson,Wendy B. Young,Adam R. Johnson,Lichuan Liu,John C. Byrd,Jennifer A. Woyach

View Articletitled, Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLL

Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92

Eugenio Morelli,Lavinia Biamonte,Cinzia Federico,Nicola Amodio,Maria Teresa Di Martino,Maria Eugenia Gallo Cantafio,Martina Manzoni,Francesca Scionti,Mehmet Kemal Samur,Annamaria Gullà,Maria Angelica Stamato,Maria Rita Pitari,Daniele Caracciolo,Settimio Sesti,Niels M. Frandsen,Marco Rossi,Antonino Neri,Mariateresa Fulciniti,Nikhil C. Munshi,Pierosandro Tagliaferri,Pierfrancesco Tassone

View Articletitled, Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92

Supplemental data

THROMBOSIS AND HEMOSTASIS

Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway

Coline Haxaire,Narine Hakobyan,Tania Pannellini,Camila Carballo,David McIlwain,Tak W. Mak,Scott Rodeo,Suchitra Acharya,Daniel Li,Jackie Szymonifka,Xiangqian Song,Sébastien Monette,Alok Srivastava,Jane E. Salmon,Carl P. Blobel

View Articletitled, Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway

Supplemental data

von Willebrand factor enhances microvesicle-induced vascular leakage and coagulopathy in mice with traumatic brain injury

Yingang Wu,Wei Liu,Yuan Zhou,Tristan Hilton,Zilong Zhao,Min Wang,Jason Yeon,Katie Houck,Perumal Thiagarajan,Fangyi Zhang,Fu-Dong Shi,Xiaoping Wu,Min Li,Jing-fei Dong,Jianning Zhang

View Articletitled, von Willebrand factor enhances microvesicle-induced vascular leakage and coagulopathy in mice with traumatic brain injury

Supplemental data

BLOOD WORK

Spindle cell lesion in the bone marrow

Samuel Guzman,Sumire Kitahara

View Articletitled, Spindle cell lesion in the bone marrow

Multiple subperiosteal bone resorption in adult T-cell leukemia/lymphoma

Takefumi Katsuragi,Junichi Tsukada

View Articletitled, Multiple subperiosteal bone resorption in adult T-cell leukemia/lymphoma

Cover Image

Cover Image

Hemophilic arthropathy (HA) is a major cause of disability in hemophilia A patients. The authors show that tumor necrosis factor-α and its upstream regulators, iRhom2 and ADAM17, have a pivotal role in synovitis and bone loss in HA. This is evidenced by osteoclasts (red) resorbing bone (blue). See the article by Haxaire et al on page 1064.
Front Matter
Table of Contents
Back Matter
Editorial Board

Advertisement

Email alerts

First Edition Alert

Latest Issue Alert

Latest
Most Read
Most Cited

Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy

NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients

Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis

How I Treat Low-risk Polycythemia Vera Patients who Require Cytoreduction

How I manage major hemorrhage

Advertisement

Advertisement

Current Issue
First edition
All Issues

Collections
Abstracts
Authors

Submit to Blood
About Blood
Subscriptions

Public Access
Permissions
Alerts

Contact Us
Newsroom
Blood Classifieds

Advertising in Blood
Terms and Conditions
Twitter

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036
TEL +1 202-776-0544
FAX +1 202-776-0545

ASH Publications

Blood
Blood Advances
Blood Neoplasia
Blood Vessels, Thrombosis & Hemostasis
Hematology, ASH Education Program
ASH Clinical News
ASH-SAP
The Hematologist

American Society of Hematology

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright 2024 by American Society of Hematology

Privacy Policy
Cookie Policy
Terms of Use
Contact Us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Advertisement